Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
المؤلف الرئيسي: | Forbes, E |
---|---|
مؤلفون آخرون: | Hill, A |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2011
|
الموضوعات: |
مواد مشابهة
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
حسب: Kapulu, MC
منشور في: (2014) -
Developing novel blood-stage malaria vaccines
حسب: Douglas, AD
منشور في: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
حسب: Bauza, K
منشور في: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
حسب: de Cassan, S
منشور في: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
حسب: Elias, SC
منشور في: (2014)